Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Danielle M. Gainer, Celeste Wong, Jared A. Embree, Nina Sardesh, Amna Amin & Natalie Lester. (2023) Effects of Telehealth on Dropout and Retention in Care among Treatment-Seeking Individuals with Substance Use Disorder: A Retrospective Cohort Study. Substance Use & Misuse 58:4, pages 481-490.
Read now
Read now
Crystal Fuller Lewis, Sharifa Z. Williams, Babak Tofighi, Helen-Maria Lekas, Adriana Joseph, Alexis Rivera & Silvia C. Amesty. (2022) Internet use and uptake of a web-based prevention and risk reduction intervention for persons who use drugs in New York City – WebHealth4Us study (2013–2016). Substance Abuse 43:1, pages 1120-1127.
Read now
Read now
Jenny E. Ozga, Catherine Paquette, Jennifer L. Syvertsen & Robin A. Pollini. (2022) Mobile phone and internet use among people who inject drugs: Implications for mobile health interventions. Substance Abuse 43:1, pages 592-597.
Read now
Read now
Alicia L. Nobles, Derek C. Johnson, Eric C. Leas, David Goodman-Meza, María Luisa Zúñiga, Douglas Ziedonis, Steffanie A. Strathdee & John W. Ayers. (2021) Characterizing Self-Reports of Self-Identified Patient Experiences with Methadone Maintenance Treatment on an Online Community during COVID-19. Substance Use & Misuse 56:14, pages 2134-2140.
Read now
Read now
Articles from other publishers (26)
Tyler S. Bartholomew, Hansel E. Tookes, Teresa A. Chueng, Ricky N. Bluthenthal, Lynn D. Wenger, Alex H. Kral & Barrot H. Lambdin. (2023) Availability of telehealth-based services at syringe services programs under the COVID-19 Public Health Emergency. Harm Reduction Journal 20:1.
Crossref
Crossref
Kendra Wyant, Hannah Moshontz, Stephanie B Ward, Gaylen E Fronk & John J Curtin. (2023) Acceptability of Personal Sensing Among People With Alcohol Use Disorder: Observational Study. JMIR mHealth and uHealth 11, pages e41833.
Crossref
Crossref
Katie Bailey, Daniela Abramovitz, Irina Artamonova, Peter Davidson, Tara Stamos-Buesig, Carlos F. Vera, Thomas L. Patterson, Jaime Arredondo, Jessica Kattan, Luke Bergmann, Sayone Thihalolipavan, Steffanie A. Strathdee & Annick Borquez. (2023) Drug checking in the fentanyl era: Utilization and interest among people who inject drugs in San Diego, California. International Journal of Drug Policy 118, pages 104086.
Crossref
Crossref
Sarah Kanana Kiburi, Edith Kamaru Kwobah, Saeeda Paruk & Bonginkosi Chiliza. (2023) Feasibility, acceptability and preliminary efficacy of a cognitive behavior therapy text-message intervention among individuals with opioid use disorder in Kenya: a randomized feasibility trial. BMC Digital Health 1:1.
Crossref
Crossref
Aaron Richterman, Fatemeh Ghadimi, Anne M. Teitelman, Kevin Moore, Trisha Acri, Hannah North, Kasandra Lopez, Vuthy Ou, Amelia E. Van Pelt & Florence Momplaisir. (2023) Acceptability and Feasibility of a Mobile Phone Application to Support HIV Pre-exposure Prophylaxis Among Women with Opioid Use Disorder. AIDS and Behavior.
Crossref
Crossref
Graham Shaw, Robin Schaefer, Heather-Marie A Schmidt, Annie Madden, Judy Chang, Antons Mozalevskis, Busisiwe Msimanga-Radebe, Nabeel Mangadan Konath, Annette Verster, Rachel Baggaley, Michelle Rodolph & Virginia Macdonald. (2023) Pre-exposure prophylaxis (PrEP) for HIV prevention among people who inject drugs: a global mapping of service delivery. Harm Reduction Journal 20:1.
Crossref
Crossref
Hansel E. Tookes, Asa Oxner, David P. Serota, Elizabeth Alonso, Lisa R. Metsch, Daniel J. Feaster, Jessica Ucha, Edward SuarezJr.Jr., David W. Forrest, Kathryn McCollister, Allan Rodriguez, Michael A. Kolber, Teresa A. Chueng, Sheryl Zayas, Bernice McCoy, Kyle Sutherland, Chetwyn Archer & Tyler S. Bartholomew. (2023) Project T-SHARP: study protocol for a multi-site randomized controlled trial of tele-harm reduction for people with HIV who inject drugs. Trials 24:1.
Crossref
Crossref
Nicholas C. Jacobson, Rachel E. Quist, Camilla M. Lee & Lisa A. Marsch. 2023. Digital Therapeutics for Mental Health and Addiction. Digital Therapeutics for Mental Health and Addiction
5
18
.
Aimee N.C. Campbell, Christina A. Brezing & Matisyahu Shulman. 2023. Digital Therapeutics for Mental Health and Addiction. Digital Therapeutics for Mental Health and Addiction
19
30
.
Lukas Hartl, Mathias Jachs, David Bauer, Benedikt Simbrunner, David Chromy, Teresa Binter, Lisa Steininger, Caroline Schwarz, Michael Schwarz, Lukas Burghart, Robert Strassl, Michael Trauner, Michael Gschwantler, Mattias Mandorfer & Thomas Reiberger. (2022)
HCV
hotline facilitates Hepatitis C elimination during the
COVID
‐19 pandemic
. Journal of Viral Hepatitis 29:12, pages 1062-1072.
Crossref
Crossref
Margaret Isioma Ojeahere, Sarah Kanana Kiburi, Paul Agbo, Rakesh Kumar & Florence Jaguga. (2022) Telehealth interventions for substance use disorders in low- and- middle income countries: A scoping review. PLOS Digital Health 1:11, pages e0000125.
Crossref
Crossref
Christina A. Brezing & Frances R. Levin. (2022) Applications of technology in the assessment and treatment of cannabis use disorder. Frontiers in Psychiatry 13.
Crossref
Crossref
Steffanie A Strathdee, Daniela Abramovitz, Alicia Harvey-Vera, Carlos F Vera, Gudelia Rangel, Irina Artamonova, Thomas L Patterson, Rylie A Mitchell & Angela R Bazzi. (2022) Correlates of Coronavirus Disease 2019 (COVID-19) Vaccine Hesitancy Among People Who Inject Drugs in the San Diego-Tijuana Border Region. Clinical Infectious Diseases 75:1, pages e726-e733.
Crossref
Crossref
Carmen N. Burrell, Melinda J. Sharon, Stephen Davis, Judith Feinberg, Elena M. Wojcik, Julia Nist, Owen Lander, Valerie Boley, Justin Burns & Ian B. K. Martin. (2021) Using the electronic medical record to increase testing for HIV and hepatitis C virus in an Appalachian emergency department. BMC Health Services Research 21:1.
Crossref
Crossref
Kirsten J. Langdon, Caroline Scherzer, Susan Ramsey, Kate Carey, Josiah Rich & Megan L. Ranney. (2021) Feasibility and acceptability of a digital health intervention to promote engagement in and adherence to medication for opioid use disorder. Journal of Substance Abuse Treatment 131, pages 108538.
Crossref
Crossref
Hansel E. Tookes, Tyler S. Bartholomew, Edward Suarez, Elisha Ekowo, Margaret Ginoza, David W. Forrest, David P. Serota, Allan Rodriguez, Michael A. Kolber, Daniel J. Feaster, Angela Mooss, Derek Boyd, Candice Sternberg & Lisa R. Metsch. (2021) Acceptability, feasibility, and pilot results of the tele-harm reduction intervention for rapid initiation of antiretrovirals among people who inject drugs. Drug and Alcohol Dependence 229, pages 109124.
Crossref
Crossref
Lisa Steininger, David Chromy, David Bauer, Benedikt Simbrunner, Teresa Binter, Philipp Schwabl, Caroline Schmidbauer, Michael Trauner, Michael Gschwantler, Mattias Mandorfer & Thomas Reiberger. (2020) Direct patient-physician communication via a hepatitis C hotline facilitates treatment initiation in patients with poor adherence. Wiener klinische Wochenschrift 133:9-10, pages 452-460.
Crossref
Crossref
Chelsea E Canan, Tabor E Flickinger, Marika Waselewski, Alexa Tabackman, Logan Baker, Samuel Eger, Ava Lena D Waldman, Karen Ingersoll & Rebecca Dillingham. (2021)
Toward understanding the impact of mHealth features for people with HIV: a latent class analysis of
PositiveLinks
usage
. Translational Behavioral Medicine 11:1, pages 172-181.
Crossref
Crossref
Carmen Rosa, Lisa A. Marsch, Erin L. Winstanley, Meg Brunner & Aimee N.C. Campbell. (2021) Using digital technologies in clinical trials: Current and future applications. Contemporary Clinical Trials 100, pages 106219.
Crossref
Crossref
Krishna K. Bommakanti, Laramie L. Smith, Lin Liu, Diana Do, Jazmine Cuevas-Mota, Kelly Collins, Fatima Munoz, Timothy C. Rodwell & Richard S. Garfein. (2020) Requiring smartphone ownership for mHealth interventions: who could be left out?. BMC Public Health 20:1.
Crossref
Crossref
Katie Biello, Peter Salhaney, Pablo K. Valente, Ellen Childs, Jennifer Olson, Joel J Earlywine, Brandon DL Marshall & Angela R Bazzi. (2020) Ecological momentary assessment of daily drug use and harm reduction service utilization among people who inject drugs in non-urban areas: A concurrent mixed-method feasibility study. Drug and Alcohol Dependence 214, pages 108167.
Crossref
Crossref
Lisa A. Marsch, Aimee Campbell, Cynthia Campbell, Ching-Hua Chen, Emre Ertin, Udi Ghitza, Chantal Lambert-Harris, Saeed Hassanpour, August F. Holtyn, Yih-Ing Hser, Petra Jacobs, Jeffrey D. Klausner, Shea Lemley, David Kotz, Andrea Meier, Bethany McLeman, Jennifer McNeely, Varun Mishra, Larissa Mooney, Edward Nunes, Chrysovalantis Stafylis, Catherine Stanger, Elizabeth Saunders, Geetha Subramaniam & Sean Young. (2020) The application of digital health to the assessment and treatment of substance use disorders: The past, current, and future role of the National Drug Abuse Treatment Clinical Trials Network. Journal of Substance Abuse Treatment 112, pages 4-11.
Crossref
Crossref
Steffanie A. Strathdee, Alicia L. Nobles & John W. Ayers. (2019) Harnessing digital data and data science to achieve 90–90–90 goals to end the HIV epidemic. Current Opinion in HIV and AIDS 14:6, pages 481-485.
Crossref
Crossref
Babak Tofighi, Noelle Leonard, Peter Greco, Aboozar Hadavand, Michelle C. Acosta & Joshua D. Lee. (2019) Technology Use Patterns Among Patients Enrolled in Inpatient Detoxification Treatment. Journal of Addiction Medicine 13:4, pages 279-286.
Crossref
Crossref
Tarandeep Anand, Chattiya Nitpolprasert & Nittaya Phanuphak. (2017) Online-to-offline models in HIV service delivery. Current Opinion in HIV and AIDS 12:5, pages 447-457.
Crossref
Crossref
Keith J. Horvath, Sara Lammert, Sara LeGrand, Kathryn E. Muessig & José A. Bauermeister. (2017) Using technology to assess and intervene with illicit drug-using persons at risk for HIV. Current Opinion in HIV and AIDS 12:5, pages 458-466.
Crossref
Crossref